A rubbery material made utilizing a three-dimensional printer may transmit electrical signals and mechanically fold like biological tissue in predictable methods. The droplets acquire a lipid form and monolayer bilayers with other droplets in the growing network. Some of these droplets consist of membrane proteins to permit for long-range electrical conversation also, like in a nerve axon; some have different concentrations of salt to make a gradient for osmosis-powered folding. In the video above, two colored dyes are included to visualize the printing procedure.David Dove, MD, President & CEO of Aeris Therapeutics commented, ‘The attainment of the CE Mark represents the accomplishment of another significant milestone in Aeris’ mission to improve the lives of sufferers with advanced lung diseases. The timing of this approval coincides with the presentation by investigators of positive scientific outcomes from our EU clinical trials at the 2010 Annual Congress of the European Respiratory Culture in Barcelona this week. It allows us to promptly address instant demand for brand-new therapies for emphysema in the EU, a potential $7 billion market opportunity.’ Prof.